MOONLAKE IMMUNOTHERAPEUTICS Lessee, Operating Lease, Liability, to be Paid, Year One
MOONLAKE IMMUNOTHERAPEUTICS (MLTX) had Lessee, Operating Lease, Liability, to be Paid, Year One of $741.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Notes › Lessee, Operating Lease, Liability, to be Paid, Fiscal Year Maturity
us-gaap:LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths · last filed 2026-08-10
- 2026-06-30: Lessee, Operating Lease, Liability, to be Paid, Year One $741.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, to be Paid, Year One $487.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, to be Paid, Year One $1.27M.
- 2025-09-30: Lessee, Operating Lease, Liability, to be Paid, Year One $1.27M.
| Period end | Lessee, Operating Lease, Liability, to be Paid, Year One |
|---|---|
| 2026-06-30 | $741.00K 10-Q · filed 2026-08-10 |
| 2026-03-31 | $487.00K 10-Q · filed 2026-05-11 |
| 2025-12-31 | $1.27M 10-K · filed 2026-02-25 |
| 2025-09-30 | $1.27M 10-Q · filed 2025-11-05 |
| 2025-06-30 | $1.28M 10-Q · filed 2025-08-05 |
| 2025-03-31 | $1.20M 10-Q · filed 2025-05-12 |
| 2024-12-31 | $1.47M 10-K · filed 2025-02-26 |
| 2024-09-30 | $1.57M 10-Q · filed 2024-11-07 |
| 2024-06-30 | $1.45M 10-Q · filed 2024-08-07 |
| 2024-03-31 | $1.44M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.34M 10-K · filed 2024-02-29 |
| 2023-09-30 | $130.92K 10-Q · filed 2023-11-14 |
| 2023-06-30 | $132.76K 10-Q · filed 2023-08-10 |
| 2023-03-31 | $130.46K 10-Q · filed 2023-05-11 |
| 2022-12-31 | $155.30K 10-K · filed 2023-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pacira BioSciences, Inc. (PCRX) | United States | $1.020B | 69.03 |
| Savara Inc (SVRA) | United States | $1.044B | -9.10 |
| Janux Therapeutics, Inc. (JANX) | United States | $1.019B | -9.15 |
| MANNKIND CORP (MNKD) | United States | $1.058B | -30.41 |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |
| Corvus Pharmaceuticals, Inc. (CRVS) | United States | $0.994B | -23.25 |
| Kura Oncology, Inc. (KURA) | United States | $0.967B | -3.29 |
| Arbutus Biopharma Corp (ABUS) | $0.965B | 6.19 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |